Cargando…

Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus

Type II diabetes (T2D) may worsen the course of hepatitis C virus infection with a greater risk of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In chronic viral infections, the deranged B cell subset signifies uncontrolled disease. The study aimed to verify the relation between B cell su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelwahab, Fadwa A., Hassanein, Khaled M., Hetta, Helal F., Abdelmalek, Mohamed O., Zahran, Asmaa M., El-Badawy, Omnia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683559/ https://www.ncbi.nlm.nih.gov/pubmed/33230233 http://dx.doi.org/10.1038/s41598-020-77416-0

Ejemplares similares

Survival outcomes of CD34(+)CD38(−)LSCs and their expression of CD123 in adult AML patients
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Deranged Tyrosine Metabolism in Cirrhosis
por: Fulenwider, J. Timothy, et al.
Publicado: (1978)

Delineation of T cell subsets in chronic rhinosinusitis with nasal polyps
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2018)

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
por: Kerbert, Annarein J. C., et al.
Publicado: (2015)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

T cell subsets, regulatory T, regulatory B cells and proinflammatory cytokine profile in Schistosoma haematobium associated bladder cancer: First report from Upper Egypt
por: Mohammed, Sara Abdelal, et al.
Publicado: (2023)

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study
por: Sarvari, Jamal, et al.
Publicado: (2013)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?
por: Zahran, Asmaa M., et al.
Publicado: (2023)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption
por: Zahran, Asmaa M, et al.
Publicado: (2021)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
por: Ye, Fangzhou, et al.
Publicado: (2023)

Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
por: Hammad, Reham, et al.
Publicado: (2023)

Treatise on Mental Derangement, and on Hospitals for the Deranged
Publicado: (1829)

Treatise on Mental Derangement, and on Hospital for the Deranged
Publicado: (1829)

Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2019)

Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Factors Associated with Appropriate Hepatocellular Carcinoma (HCC) Screening Among Chronic Hepatitis C (HCV) Patients with Cirrhosis at an Urban Safety-net Hospital System
por: Cabrera, Nicolo, et al.
Publicado: (2017)

Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egypt
por: Koutb, Fayed, et al.
Publicado: (2017)

Pretreatment detection of circulating and tissue CD133(+) CD44(+) cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer
por: Zahran, Asmaa M, et al.
Publicado: (2019)

Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
por: Zahran, Asmaa M, et al.
Publicado: (2019)

Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines
por: Abd Ellah, Noura H, et al.
Publicado: (2019)

Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV
por: Akkiz, H, et al.
Publicado: (2020)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone
por: Elsayh, Khalid Ibrahim, et al.
Publicado: (2022)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
por: Hetta, Helal F., et al.
Publicado: (2020)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
por: Deorukhkar, Durga, et al.
Publicado: (2023)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article
por: Milosevic, Ivana, et al.
Publicado: (2023)

Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis
por: El-Maraghy, Shohda A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u2ggfko5lsfpld4afs8cudn1hj